Galena Biopharma -6.4% as Jim Cramer says take profits

|About: Galena Biopharma, Inc. (GALE)|By:, SA News Editor

Galena Biopharma (GALE -6.4%) opens with a thud after Jim Cramer suggests investors take profits after shares more than tripled during the past three months.

Cramer questioned CEO Dr. Mark Ahn about the history of failures for drugs similar to NeuVax, GALE's lead clinical candidate, saying he was skeptical about the drug's chances for approval.

In response to criticisms, Ahn says "of the patients in the Phase II study of NeuVax, 0% of those patients had a recurrence of cancer."